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ABSTRACT 
Southeast of Iran is an endemic area for Malaria and Crimean-Congo hemorrhagic fever (CCHF). 
In 1999, we faced with an outbreak of CCHF in Sistan and Baluchistan Province, in the border of 
Pakistan and Afghanistan. The most cases of Malaria in Iran are also reported from this area. This 
article presents a 17-year- old woman who admitted to our hospital because of acute fever, head-
ache, epistaxis, hemorrhagic lesions on the skin and vaginal bleeding. Finally, she was recog-
nized as a case that was co –infected with CCHF and malaria. 
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Case report 
 
A -17-year-old woman from Zahedan 
(South- eastern Iran) referred to our hospital 
with a history of acute fever, headache, 
myalgia, and mild epistaxis from 36 hours 
ago. During the first day of illness, she had 
received acetaminophen and non-steroidal 
anti-inflammatory drugs. Twelve hours later, 
she noticed hemorrhage into the skin more 
on the chest and her abdomen. Therefore, 
she was admitted to infectious ward. She did 
not have any abdominal pain, vomiting, 
cough, and flu like syndrome. She denied 
any contact with animals and she did not 
have any history of recent travel and trauma. 
On physical examination, she looked pale. 
There were small hemorrhages under the 
skin especially on the chest and abdomen. 
Spleen was palpable. The findings of the re-
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mainder of the physical examinations were 
normal. The patient's hemoglobin level was 
9,1g/dL, and her platelet count was 18,000 
platelets/mm
3. Erythrocyte sedimentation 
rate was 25 mm per h. SGOT and SGPT 
were more than five upper normal limits. 
Prothrombin time (PT) was 17. Other labora-
tory values, including the results of urinaly-
sis, and biochemical tests were within nor-
mal limits. Urine and blood cultures were 
negative. Diagnostic tests for hepatitis B and 
C viruses were negative. Radiography of 
chest was normal. On 3
th day of hospitaliza-
tion, blood smear revealed Plasmodium fal-
ciparum and so, she had the symptoms of 
severe malaria, and she received intravenous 
quinine. Because, at this time, we faced with 
many patients with CCHF, we sent a blood 
sample to Reference Laboratory, Tehran, 
Iran for evaluation of CCHF. She treated by 
oral ribavirin and received platlete and fresh 
frozen plasma. She had also received ceftri-
axone and amikacin from the first day of ad-
mission. Unfortunately, on 4
th day of admis-
sion, she deteriorated and sent to ICU. On 
the same day, she died due to massive gas-
trointestinal (GI) and vaginal hemorrhage. 
Three weeks later, we received a positive 
test (RT-PCR and IgM-ELISA) for CCHF.  
 
Discussion 
 
Malaria is an infectious disease which 
caused by a parasite called Plasmodium (1). 
It is mainly widespread in tropical and sub-
tropical areas like as many countries in Af-
rica, Asia, South, and Central America (2). 
Transmission occurs through the bite of in-
fected mosquitoes. In human body parasite 
multiply in the liver and then release and in-
fects red blood cells. Malaria could be a life 
–threatening disease by disrupting the blood 
supply to the vital organs, if it is diagnosed 
late and not treated soon (1,2). Symptoms of 
malaria include fever, shivering, headache, 
myalgia and sometimes-abdominal pain, 
vomiting, cough, flu like syndrome or ane-
mia due to hemolysis (1). 
Similarly, these symptoms can be observed 
in CCHF. CCHF is a viral hemorrhagic fever 
and caused by infection with a tick-borne 
virus  (Nairovirus) in the family of Bun-
yaviridae (3). CCHF is found throughout the 
Central Asia, Southern Europe, Africa, and 
In the Middle East (4-6).Ticks; especially 
those of the genus,  Hyalomma,  are both a 
reservoir and a vector for the CCHF virus. 
Animals, such as sheep, cattle, goat, camel, 
and sometimes hare serve as important hosts 
for the virus (1, 5, 6). Transmission to hu-
mans occurs through contact with infected 
animal blood or tick bite. Nosocomial infec-
tion has also reported in hospitals due to un-
suitable sterilization of medical equipment 
(8). CCHF infection was rarely reported in 
Iran before 1999. Since spring 1999 epi-
demic of this infection has been occurred in 
some regions of Iran especially in Sistan and 
Baluchistan, Southeast of Iran (1, 3, 7). The 
disease usually occurs in young or middle 
age men. Symptoms are acute fever, head-
ache, myalgia, vomiting, abdominal pain, or 
flu like syndrome. Hemorrhagic mani-
festations can occur in this disease due to 
thrombocytopenia or DIC the same as can be 
observed in malaria (1).Therefore, in en-
demic area, these both diseases can mistake 
together and could be together as co-infec-
tion. In our knowledge, our patient is the 
first case of co-infection malaria and CCHF 
in this region. We recommend every physi-
cian should be aware of co-infection malaria 
and CCHF in area where two both infections 
are endemic. 
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